AI & ChatGPT searches , social queriess for REFANEZUMAB

Search references for REFANEZUMAB. Phrases containing REFANEZUMAB

See searches and references containing REFANEZUMAB!

AI searches containing REFANEZUMAB

REFANEZUMAB

  • Refanezumab

    • Monoclonal antibody

    Refanezumab (GSK249320) is a monoclonal antibody designed for the recovery of motor function after stroke. This drug was developed by GlaxoSmithKline

    Refanezumab

    Refanezumab

  • Donanemab

    • Monoclonal antibody against amyloid beta

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Donanemab

    Donanemab

  • Anti-amyloid antibodies

    • Drug class

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Anti-amyloid antibodies

    Anti-amyloid_antibodies

  • Monoclonal antibody

    • Antibodies from clones of the same blood cell

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Monoclonal antibody

    Monoclonal antibody

    Monoclonal_antibody

  • Evolocumab

    • Pharmaceutical drug

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Evolocumab

    Evolocumab

  • Humanized antibody

    • Antibodies from non-human species made nearly identical with human ones

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Humanized antibody

    Humanized_antibody

  • Lecanemab

    • Monoclonal antibody against amyloid beta

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Lecanemab

    Lecanemab

  • Bimagrumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Bimagrumab

    Bimagrumab

  • Denosumab

    • Human monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Denosumab

    Denosumab

  • Idarucizumab

    • Medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Idarucizumab

    Idarucizumab

  • Prasinezumab

    • Experimental monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Prasinezumab

    Prasinezumab

  • Bevacizumab

    • Medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Bevacizumab

    Bevacizumab

  • Abciximab

    • Pharmaceutical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Abciximab

    Abciximab

    Abciximab

  • Emicizumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Emicizumab

    Emicizumab

    Emicizumab

  • Burosumab

    • Monoclonal antibody designed to treat X-linked hypophosphatemia

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Burosumab

    Burosumab

  • Bedinvetmab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Bedinvetmab

    Bedinvetmab

    Bedinvetmab

  • Romosozumab

    • Pharmaceutical drug

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Romosozumab

    Romosozumab

  • List of therapeutic monoclonal antibodies

    • paroxysmal nocturnal hemoglobinuria, atypical hemolytic uremic syndrome Refanezumab mab humanized myelin-associated glycoprotein recovery of motor function

    List of therapeutic monoclonal antibodies

    List of therapeutic monoclonal antibodies

    List_of_therapeutic_monoclonal_antibodies

  • Trevogrumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Trevogrumab

    Trevogrumab

  • Solanezumab

    • Monoclonal antibody medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Solanezumab

    Solanezumab

  • Marstacimab

    • Medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Marstacimab

    Marstacimab

  • Caplacizumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Caplacizumab

    Caplacizumab

  • Bapineuzumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Bapineuzumab

    Bapineuzumab

  • Concizumab

    • Medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Concizumab

    Concizumab

  • Fremanezumab

    • Pharmaceutical biological monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Fremanezumab

    Fremanezumab

  • Anti-α-synuclein drug

    • Drugs that inhibit α-synuclein

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Anti-α-synuclein drug

    Anti-α-synuclein_drug

  • Bococizumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Bococizumab

    Bococizumab

  • Abelacimab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Abelacimab

    Abelacimab

  • Galcanezumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Galcanezumab

    Galcanezumab

    Galcanezumab

  • Gantenerumab

    • Monoclonal antibody protein

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Gantenerumab

    Gantenerumab

    Gantenerumab

  • Aducanumab

    • Monoclonal antibody against amyloid beta

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Aducanumab

    Aducanumab

  • Izenivetmab

    • Veterinary medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Izenivetmab

    Izenivetmab

  • Amlenetug

    • Pharmaceutical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Amlenetug

    Amlenetug

  • Relfovetmab

    • Veterinary medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Relfovetmab

    Relfovetmab

  • Alirocumab

    • Pharmaceutical drug

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Alirocumab

    Alirocumab

  • Inclacumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Inclacumab

    Inclacumab

  • Erenumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Erenumab

    Erenumab

    Erenumab

  • Crenezumab

    • Antibody tested against Alzheimer's

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Crenezumab

    Crenezumab

  • Stamulumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Stamulumab

    Stamulumab

  • Eptinezumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Eptinezumab

    Eptinezumab

  • Semorinemab

    • Anti-tau monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Semorinemab

    Semorinemab

  • Etaracizumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Etaracizumab

    Etaracizumab

  • Ramucirumab

    • Pharmaceutical drug

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Ramucirumab

    Ramucirumab

  • Faricimab

    • Medication for macular degeneration

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Faricimab

    Faricimab

    Faricimab

  • Tanezumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Tanezumab

    Tanezumab

  • Enoticumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Enoticumab

    Enoticumab

  • Brolucizumab

    • Pharmaceutical drug

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Brolucizumab

    Brolucizumab

  • Evinacumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Evinacumab

    Evinacumab

  • Devextinetug

    • Pharmaceutical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Devextinetug

    Devextinetug

  • Ranibizumab

    • Pharmaceutical drug

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Ranibizumab

    Ranibizumab

  • Blosozumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Blosozumab

    Blosozumab

  • Bentracimab

    • Medication

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Bentracimab

    Bentracimab

  • Demcizumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Demcizumab

    Demcizumab

  • Ozanezumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Ozanezumab

    Ozanezumab

  • Cinpanemab

    • Experimental monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Cinpanemab

    Cinpanemab

  • Rinucumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Rinucumab

    Rinucumab

  • Vanucizumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Vanucizumab

    Vanucizumab

  • Orticumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Orticumab

    Orticumab

  • Fasinumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Fasinumab

    Fasinumab

  • Fulranumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Fulranumab

    Fulranumab

  • Indium (111In) biciromab

    • Pharmaceutical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Indium (111In) biciromab

    Indium_(111In)_biciromab

  • Opicinumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Opicinumab

    Opicinumab

  • Icrucumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Icrucumab

    Icrucumab

  • Indium (111In) imciromab

    • Pharmaceutical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Indium (111In) imciromab

    Indium_(111In)_imciromab

  • Ascrinvacumab

    • Chemical compound

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Ascrinvacumab

    Ascrinvacumab

  • Ponezumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Ponezumab

    Ponezumab

  • Ralpancizumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Ralpancizumab

    Ralpancizumab

  • Volociximab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Volociximab

    Volociximab

  • Nesvacumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Nesvacumab

    Nesvacumab

  • Alacizumab pegol

    • Pharmaceutical drug

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Alacizumab pegol

    Alacizumab_pegol

  • Tadocizumab

    • Monoclonal antibody

    Crenezumab† Eptinezumab Fremanezumab Galcanezumab Ozanezumab Ponezumab Refanezumab Semorinemab Solanezumab Tanezumab† Angiogenesis inhibitor Humanized Ranibizumab

    Tadocizumab

    Tadocizumab

AI & ChatGPT searchs for online references containing REFANEZUMAB

REFANEZUMAB

AI search references containing REFANEZUMAB

REFANEZUMAB

AI search queriess for Facebook and twitter posts, hashtags with REFANEZUMAB

REFANEZUMAB

Follow users with usernames @REFANEZUMAB or posting hashtags containing #REFANEZUMAB

REFANEZUMAB

Online names & meanings

  • Aarnika

    • Girl/Female

    Indian

    Aarnika

    Goddess Lakshmi

  • Khushtar

    • Boy/Male

    Arabic, Muslim

    Khushtar

    Surrounded by Happiness

  • Sugapriyan

    • Boy/Male

    Hindu

    Sugapriyan

    Wish to have peace

  • Hutchcroft

    • Surname or Lastname

    English (Yorkshire)

    Hutchcroft

    English (Yorkshire) : unexplained. Compare Hutchcraft.

  • Mikeal

    • Boy/Male

    American, Australian

    Mikeal

    Like God

  • MELIOR

    • Female

    Cornish

    MELIOR

    , better.

  • CHICO

    • Male

    Portuguese

    CHICO

     Pet form of Portuguese/Spanish Francisco, CHICO means "French." Compare with another form of Chico.

  • Kral

    • Boy/Male

    Czechoslovakian

    Kral

    King.

  • Line

    • Girl/Female

    Norse

    Line

    Distinguished.

  • Malvinia

    • Girl/Female

    Latin

    Malvinia

    Sweet friend.

AI search & ChatGPT queriess for Facebook and twitter users, user names, hashtags with REFANEZUMAB

REFANEZUMAB

Top AI & ChatGPT search, Social media, medium, facebook & news articles containing REFANEZUMAB

REFANEZUMAB

AI searchs for Acronyms & meanings containing REFANEZUMAB

REFANEZUMAB

AI searches, Indeed job searches and job offers containing REFANEZUMAB

Other words and meanings similar to

REFANEZUMAB

AI search in online dictionary sources & meanings containing REFANEZUMAB

REFANEZUMAB